Skip to main content
. 2021 Feb 1;9(2):138. doi: 10.3390/biomedicines9020138

Figure 1.

Figure 1

Oncolytic viruses have been engineered to exhibit selective tropism for cancer cells. Mechanistically, this entails that they rarely infect normal tissues, therefore reducing the systemic signs and symptoms that would be normally experienced with parental strains.